Amwill Health Care IPO is scheduled to open on February 5, 2025, and close on February 7, 2025. The company seeks to raise ₹59.98 crores from a Book Built Issue IPO. This includes a fresh issue of ₹48.88 crores and an offer for sale of 10,00,000 equity shares at a face value of ₹10 per share.
Amwill Health Care is a well-known derma-cosmetics company that has been operational since 2009. This company deals in dermatological, cosmeceutical, and aesthetic skincare products. Amwill Health Care is associated with the development of skincare solutions in collaboration with manufacturers, distributors, and third-party developers.
| Detail | Information |
|---|---|
| IPO Date | February 5, 2025 to February 7, 2025 |
| Listing Date | February 12, 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹105 to ₹111 per share |
| Lot Size | 1,200 Shares |
| Total Issue Size | 54,03,600 shares (aggregating up to ₹59.98 Cr) |
| Fresh Issue | 44,03,600 shares (aggregating up to ₹48.88 Cr) |
| Offer for Sale | 10,00,000 shares of ₹10 (aggregating up to ₹11.10 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,56,00,000 shares |
| Share Holding Post Issue | 2,00,03,600 shares |
| DRHP Draft Prospectus | Click Here |
| RHP Draft Prospectus | Click Here |
| Anchor Investors List | Click Here |
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹1,33,200 |
| Retail (Max) | 1 | 1,200 | ₹1,33,200 |
| HNI (Min) | 2 | 2,400 | ₹2,66,400 |
Growing Product Range: Introduces seven new skincare products, including Proputor Tabs, XL Hydra Cream, Ozederm Cream, etc.
Presence in Major Markets: Strong foothold in Karnataka, Andhra Pradesh, and Telangana with further expansion plans.
Quality Focus: Uses high-quality ingredients to ensure purity and effectiveness in skincare treatments.
Amwill Health Care is a well-known derma-cosmetics company that has been operational since 2009. This company deals in dermatological, cosmeceutical, and aesthetic skincare products. Amwill Health Care is associated with the development of skincare solutions in collaboration with manufacturers, distributors, and third-party developers.
Amwill Healthcare Limited
No. 157, 1st Floor,
2nd Main, r, 2nd Main, 3rd Cross Chamrajpet
Bangalore – 560018
Phone: +91 8043026281
Email: amwill@amwillhealthcare.com
Website: https://www.amwillhealthcare.com/
The IPO opens on February 5, 2025, and closes on February 7, 2025.
The IPO price band is ₹105 to ₹111 per share.
The minimum lot size is 1,200 shares.
The allotment date is February 10, 2025.
The listing is scheduled for February 12, 2025.
The total issue size is ₹59.98 crores, comprising a fresh issue of ₹48.88 crores and an OFS of ₹11.10 crores.
Investors can apply via UPI through Zerodha, Groww, AngelOne, or their broker’s platform.
Based on financials, it appears to be a good long-term investment.
GMP changes daily. Check updated GMP before investing.
The major risks include SME IPO volatility, competition, and dependency on third-party manufacturers.
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | ₹28.89 Crore | ₹18.98 Crore | ₹12.39 Crore | ₹6.59 Crore |
| Revenue | ₹23.25 Crore | ₹44.28 Crore | ₹30.28 Crore | ₹27.62 Crore |
| Profit After Tax | ₹6.52 Crore | ₹12.54 Crore | ₹3.11 Crore | ₹2.57 Crore |
| Net Worth | ₹23.68 Crore | ₹17.16 Crore | ₹4.6 Crore | ₹1.49 Crore |
| Reserves and Surplus | ₹8.08 Crore | ₹17.11 Crore | ₹4.57 Crore | ₹1.46 Crore |
Amount in ₹ Crore
